Cancellation of kids’ asthma medication continues to cause turmoil for Mass. families
Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...
pharmaphorum24 天
Asthma and COPD patient adherence: the right inhaler
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience ...
Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.
pharmaphorum4 天
Teva launches digital asthma and COPD rescue inhaler in US
Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...
“Game-Changing” New Treatment for Asthma Could Save Millions From Fatal Lung Attacks
A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...
First new treatment for asthma and COPD in half a century—new study
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...
The Independent15 天
Doctors urged to ditch blue inhalers for asthma treatment over climate concerns
“Most people with asthma have one or more preventer ... “Flutiform and Symbicort metered dose inhalers contain a type of propellant that has a more powerful greenhouse effect than other ...